PTPN11-associated Noonan syndrome presenting with neonatal spontaneous hemorrhagic pleural effusion: a case report
This case report describes a rare neonatal presentation of PTPN11-associated Noonan syndrome characterized by spontaneous hemorrhagic pleural effusion, highlighting the importance of early genetic evaluation for unexplained pleural effusions and suggesting sirolimus as a potential therapeutic option for associated lymphatic abnormalities despite the patient's eventual mortality due to multisystem complications.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Newborns are fragile, and when they arrive early, their bodies often struggle to adapt to life outside the womb. Sometimes, fluid that should be absorbed or circulated instead builds up in the chest or around the organs, a condition that can be difficult to treat. In rare cases, this fluid is not just water or clear lymph, but blood. When a baby presents with unexplained bleeding into the chest cavity, doctors must act quickly to find the cause, ruling out infections, injuries, or blood disorders. This diagnostic challenge sits at the intersection of genetics and critical care, where understanding the body's blueprint can explain why a seemingly healthy pregnancy resulted in a life-threatening emergency for the infant.
A team of doctors at the Children's Hospital of Zhejiang University School of Medicine recently documented a particularly difficult case involving a male infant born at 29 weeks and 2 days of gestation. The baby weighed 1,950 grams and was delivered by cesarean section due to an excess of amniotic fluid. Shortly after birth, the infant developed severe trouble breathing and required a breathing tube and mechanical ventilation. Within hours, the baby's condition worsened, showing signs of generalized swelling and a lack of urine production. Despite aggressive treatment with diuretics and other supportive measures, the swelling did not go down. Instead, the infant began to accumulate fluid in the chest that was dark red and bloody, a condition known as hemorrhagic pleural effusion.
The medical team faced a complex puzzle. They drained the fluid multiple times, but it kept returning. Standard tests ruled out common causes such as bacterial infection, cancer, autoimmune diseases, or problems with the baby's blood clotting system. The fluid contained red blood cells and immune cells, but no cancer cells. The baby also had a heart condition, with thickened heart walls and high pressure in the lung arteries, which are known complications in certain genetic disorders. Physical examination revealed soft, compressible lumps on the chest wall, and ultrasound imaging suggested these were abnormal blood or lymph vessels. The doctors suspected a deeper issue related to how the baby's lymphatic system, which manages fluid drainage, had formed.
To solve the mystery, the team performed a comprehensive genetic analysis on the infant and his parents. They discovered a specific change in a gene called PTPN11, which is known to play a major role in how cells grow and communicate. This specific genetic variant, inherited from the mother, confirmed a diagnosis of Noonan syndrome type 1. This condition is a genetic disorder that affects many parts of the body, often causing distinctive facial features, heart defects, and short stature. In this case, the syndrome manifested as a severe abnormality in the lymphatic system, leading to the spontaneous bleeding into the chest. The mother, who carried the same genetic change, had a history of short stature and thyroid issues, consistent with the condition.
Once the genetic cause was identified, the medical team shifted their treatment strategy. They administered a medication called sirolimus, which is known to help stabilize abnormal blood and lymph vessels by blocking a specific pathway in the body that controls cell growth. Along with a steroid medication, this treatment helped reduce the fluid in the chest and the abdomen. The bleeding slowed, and the swelling began to improve. However, the infant's condition remained critical due to extreme prematurity, persistent lung problems, and severe heart issues. Despite the partial success of the treatment, the family made the difficult decision to withdraw life-sustaining care. The infant passed away on the 46th day of life.
This case report highlights that spontaneous bleeding into the chest can be a rare and severe sign of Noonan syndrome in newborns, even before other classic symptoms appear. It suggests that the lymphatic system in these infants can be so fragile that it leaks blood without any external injury. While the use of sirolimus showed promise in managing the fluid buildup, the overall outcome for this infant was tragic due to the severity of the multisystem disease. The report emphasizes that when a newborn presents with unexplained fluid accumulation and swelling, doctors should consider genetic testing for Noonan syndrome early in the process. Identifying the genetic cause can guide treatment choices, such as using medications that target the underlying vascular abnormalities, offering a potential path forward for similar cases in the future.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.